Evaluation of convalescent whole blood for treating Ebola Virus Disease in Freetown, Sierra Leone

[1]  G. Marano,et al.  Convalescent plasma: new evidence for an old therapeutic tool? , 2016, Blood transfusion = Trasfusione del sangue.

[2]  P. Horby,et al.  Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea. , 2016, The New England journal of medicine.

[3]  Peter G. Smith,et al.  The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the Field , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  T. Decroo,et al.  The Contribution of Ebola Viral Load at Admission and Other Patient Characteristics to Mortality in a Médecins Sans Frontières Ebola Case Management Centre, Kailahun, Sierra Leone, June–October 2014 , 2015, The Journal of infectious diseases.

[5]  K. Jacobsen,et al.  Ebola in Freetown area, Sierra Leone--a case study of 581 patients. , 2015, The New England journal of medicine.

[6]  J. Seghatchian,et al.  Ebola virus convalescent blood products: Where we are now and where we may need to go , 2014, Transfusion and Apheresis Science.

[7]  J. Strong,et al.  Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp™ , 2014, Nature.

[8]  W. Lim,et al.  The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis , 2014, The Journal of infectious diseases.

[9]  R. Tedder,et al.  Strategies for screening blood donors to source convalescent H1N1v plasma for intervention therapy , 2012, Vox sanguinis.

[10]  Kwok-Hung Chan,et al.  Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  P. Jahrling,et al.  Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates. , 2007, The Journal of infectious diseases.

[12]  P. Chan,et al.  Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital , 2005, The Journal of antimicrobial chemotherapy.

[13]  M. Radosevich,et al.  Treatment of severe acute respiratory syndrome with convalescent plasma. , 2003, Hong Kong medical journal = Xianggang yi xue za zhi.

[14]  D. Campbell,et al.  POOLED HUMAN IMMUNOGLOBULIN INHIBITS IL-4 BUT NOT IFN-γ OR TNF-α SECRETION FOLLOWING IN VITRO STIMULATION OF MONONUCLEAR CELLS WITH STAPHYLOCOCCAL SUPERANTIGEN , 1999 .

[15]  R. Colebunders,et al.  Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee. , 1999, The Journal of infectious diseases.

[16]  Ali S Khan,et al.  Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: determinants of survival. , 1999, The Journal of infectious diseases.

[17]  D. Courtois.  [Ebola virus three years later (author's transl)]. , 1979, Medecine tropicale : revue du Corps de sante colonial.

[18]  G. Lloyd,et al.  A case of Ebola virus infection. , 1977, British medical journal.

[19]  Huber Hg.  Status of treatment with poliomyelitis convalescent serum , 1953 .

[20]  T. Gundersen.  Convalescent Blood for Treatment of Herpes Zoster Ophthalmicus: Second Report. , 1940, Transactions of the American Ophthalmological Society.

[21]  O. Mejabi,et al.  Convalescent Serum Therapy as Rapid Advance Treatment for Ebola in West Africa , 2015 .

[22]  D. Campbell,et al.  Pooled human immunoglobulin inhibits IL-4 but not IFN-gamma or TNF-alpha secretion following in vitro stimulation of mononuclear cells with Staphylococcal superantigen. , 1999, Cytokine.

[23]  D. Courtois.  Ebola virus three years later. , 1979 .

[24]  H. G. Huber.  [Status of treatment with poliomyelitis convalescent serum]. , 1953, Kinderarztliche Praxis.